"The addition of the Essentra Porous Technologies business increases our capabilities for our customers," said Steve Felice, Filtration Group CEO. "This acquisition furthers our mission of becoming an innovative global filtration solution provider."
Essentra Porous Technologies' products support essential biomedical procedures such as disease detection and prevention, laboratory testing and genetic analysis. Its innovations are found in a wide range of products from electronics to household applications.
Colin Day, Essentra plc Chief Executive, said, "As a developer and manufacturer of custom vapor- and fluid-handling components, Porous Technologies will add greatly to Filtration Group's technology portfolio."
The acquisition broadens Filtration Group's global presence by adding operations in the U.S., Asia, and Europe.